Great health era: what is the direction of modernization of traditional Chinese medicine industry

Source: fulcrum 2015-01-21 World Health Organization report "meet the challenges of the 21st century" points out that medicine in the 21st century should not continue to focus on diseases, but on human health Paul pierser, a famous American economist, in his book the fifth wave of wealth, called the health industry the star of the future after the Internet revolution As the treasure and quintessence of the Chinese nation, traditional Chinese medicine has its advantages in health care and health preservation The development of modern science and technology and the integration of multi disciplines are providing strong support for the modernization of traditional Chinese medicine New products of traditional Chinese medicine, such as traditional Chinese medicine daily chemical, traditional Chinese medicine health care products, traditional Chinese medicine drinks, are becoming an important development direction of the modernization of traditional Chinese medicine, and are valued by the government, enterprises and all sectors of society Traditional Chinese medicine products are becoming the forerunner of the rejuvenation of traditional Chinese culture On December 6, 2014, the Fifth China Modern Chinese medicine industry development forum was held in Wuhan Optical Valley Biological city There are 300 representatives from relevant national ministries and research institutions, local governments and industrial parks, domestic and foreign entrepreneurs, representatives from more than 20 provincial hospitals of traditional Chinese medicine and social figures concerned about the development of Chinese medicine industry More than people attended the meeting They stood in their own research direction and the position of enterprise development, and focused on the theme of "new products of traditional Chinese medicine and modernization of traditional Chinese medicine", they discussed and exchanged a series of new product development and modernization of traditional Chinese medicine, such as traditional Chinese Medicine beverage, traditional Chinese medicine health care products, and traditional Chinese medicine daily chemical The modernization of traditional Chinese medicine needs to promote Julien (former Minister of the Ministry of science and technology of the people's Republic of China) Forum on the development of modern Chinese medicine industry in the top-level design, which is indeed well done, but the forum can't just sit on the sidelines and talk about things instead of doing things, and the ultimate influence should be implemented on the executive force, which is really powerful The modernization of traditional Chinese medicine is a very important thing We are faced with the coexistence of "danger" and "opportunity" At this forum, we established the national strategic alliance for technological innovation of traditional Chinese medicine industry and the Professional Committee for protection and innovation of traditional Chinese medicine of China Association of traditional Chinese medicine, which shows that the strength of traditional Chinese medicine industry is gathering and becoming a collective strength, which is a good practice The State Council is drawing up the 13th five year plan, which is an opportunity for the traditional Chinese medicine industry From the perspective of national strategic development, from the perspective of industrial structure optimization, with the development of people's Livelihood Science and technology and the creation of projects for the benefit of the people as a breakthrough point, we should take the new products of traditional Chinese medicine and the modernization of traditional Chinese medicine as a handle, expound the importance and urgency of the new products of traditional Chinese medicine and the modernization of traditional Chinese medicine to national leaders, and strive to make them in the 13th five year plan The plan has been listed as a major national special project, so as to form a major breakthrough at the national level As we all know, the 863 program was a letter written by four scientists to Comrade Xiaoping explaining the importance of high-tech development Comrade Xiaoping immediately commented that this is a very important thing and needs to be studied well I have always supported the "863" plan Later, the "863" plan was discussed and approved by the Political Bureau of the Central Committee Later, general Zhang Zhen told me that thanks to the "863" plan, our high-tech development has been shortened by at least 10 years This is a good example I hope that the traditional Chinese medicine industry can seize the opportunity to do things well At present, the national economic and industrial structure is transforming China's pharmaceutical industry is still developing in double digits, with the output value reaching 1.5 trillion yuan in 2013 and 1.7 trillion yuan in the first three quarters of 2014 The development of traditional Chinese medicine industry is also good In the first three quarters of 2014, the total output value was 404.5 billion yuan, and the output value of decoction pieces was 104.7 billion yuan The total output value of these two items was more than 500 billion yuan, which was the same as that of 2013 In terms of numbers alone, I think the development is not bad However, compared with the same period in 2013, the growth rate still has a downward trend In 2013, the growth rate of traditional Chinese medicine industry is 23%, while in 2014, the growth rate of decoction pieces is expected to be 13%, and the growth rate of proprietary Chinese medicine is expected to be 16%, both lower than that in 2013 What's more worrisome is that 11 provinces have a downward trend in the production of proprietary Chinese medicine, and 9 provinces have a downward trend in the decoction piece industry, mainly due to the lack of intellectual property protection and innovation of traditional Chinese medicine products, which has gradually become the bottleneck of the development of the whole traditional Chinese medicine industry At present, many countries in the world are paying attention to and studying Chinese patent medicine If we do not improve in this respect, we will lag behind other countries in the research and development of Chinese patent medicine Li Daning (former deputy director of the State Administration of traditional Chinese Medicine) will surely promote the modernization of traditional Chinese medicine and the development of traditional Chinese medicine industry, which is a very important commanding point in international competition Research and development of new products of traditional Chinese medicine is a very characteristic part of traditional Chinese medicine In the process of research and development, there will be constant collision of ideas and innovation of ideas In the process of integration of traditional culture and modern science and technology, new demands will appear In the process of R & D, how to examine, judge and manage new products, including making relevant policies and regulations, are worth studying The research and development of new products of traditional Chinese medicine is a very connotative and worthy field, and also a systematic research process At present, there are many ideas about the research and development of new products of traditional Chinese medicine At the same time, we should actively explore the research and development path and carefully summarize the experience and lessons I believe that the research and development of new products of traditional Chinese medicine should not only be combined with the comprehensive utilization and development of traditional Chinese medicine resources, but also be connected with the comprehensive utilization of traditional Chinese medicine In addition, the research and development of new products of traditional Chinese medicine should be combined with how to find out the market position, how to improve people's health level and enterprise development strategy I think these problems will surely attract the attention of the government, enterprises and the people I hope that this forum can further explore these issues, especially after the establishment of the professional committee of traditional Chinese medicine protection and innovation by the traditional Chinese Medicine Association, and will certainly play its due role in the research and development of new products of traditional Chinese medicine The marketization of products is promoted by the system by Zheng Changhao (director of the Quanzhou Institute of biological materials in South Korea) Chinese traditional medicine, which is called "Korean medicine" in South Korea, but in fact, it is the pure natural plant medicine written in compendium of Materia Medica by Li Shizhen There should be actions and initiatives for the development of traditional Chinese medicine industry, including the introduction of national policies Korean medicine is also driven by strong policies in South Korea For example, we know that chemical pesticides are harmful to human body, and there are mandatory requirements for their use in South Korea Moreover, in South Korea, pork is of standard grade, and it is difficult to sell meat with antibiotics and chemicals As for the development of traditional Chinese medicine industry, South Korea and China have the same problem, that is, they are too blind in research and development and have no direction Therefore, patents and achievements can be converted into less than 18% of productivity But later, the state and research institutions jointly promoted the development of industry and science and technology, which was a strong driving force South Korea's scientific and technological innovation is constantly changing in quantity, but also in quality Some duplicate patents will not produce much effect At this time, the government will intervene It is very important that R & D of science and technology conform to the investment direction supported by government policies In South Korea, there are mandatory policies to manage patents and research results, as well as the distribution of benefits after the marketization of products For example, our field of science and technology includes research and development and market If an enterprise industrializes the achievements of research institutions, it must be forced to feed back its interests to research institutions and enterprises and institutions in proportion If the enterprise fails to do so, or the research institutions do something fake, which damages the enterprise, it has an impact on the credit of either party 。 In order to develop new products of traditional Chinese medicine, it is necessary to keep pace with the times and ensure the safety of food There is a list of medicine and food homology in the folk, but whether these herbs can be applied to the food field is still unknown Since 1983, it has been stipulated by the state that food produced from new resources can only be produced after being examined and approved by the Ministry of health The new food raw material is a kind of license, which is retained in the food safety law currently under revision New food raw materials have attribute requirements and should have the characteristics of food raw materials They should be edible, acceptable, renewable, systematic and developmental They should meet the necessary nutritional requirements They have traditional nutrients and healthy nutrients They are non-toxic and harmless They do not cause any acute, sub acute, chronic or other potential harm to human health For online application and consultation, the applicant shall indicate the contents that are not involved in business secrets and can be disclosed to the public when submitting materials, so as to reduce repeated examination and approval In accordance with the provisions of the administrative license law, experts shall review within 60 days, and the review meeting shall be held every two months, generally the last week of the bimonthly The review committee is composed of more than 9 experts, involving food, nutrition, medicine, pharmacy and other industries Request on-site defense and organize experts to conduct on-site verification For medicine food homology catalogue, it can be used as common food, and its non medicinal parts can be developed as common food It is necessary to declare new food raw materials, such as seabuckthorn leaves Chinese herbal medicines listed in the Chinese Pharmacopoeia and the catalogue of dual use of medicine and food, if used as ordinary food, shall be declared as new food raw materials Now I'd like to introduce to you the draft of "management measures for traditional Chinese medicine based on traditional food" which is currently being drafted The management method is based on the food hygiene law issued in 1987 The basis of revision includes the list of medicine and food homology according to the legal responsibilities of the food safety law At present, it can not meet the needs of the consumers in the big country with medicine and food homology in China There are 100 kinds of medicine and food substances in Singapore We need to expand the list, and the directories outside the list include ginseng, aloe, etc The scope of the definition of the administrative measures is to have traditional usage habits and be listed in the national standards for Chinese herbal medicines, including the applicable parts of animals and plants in the Pharmacopoeia of the people's Republic of China and relevant standards for Chinese herbal medicines, including food raw materials, spices and condiments The listing principles generally have five characteristics: first, they are in line with the provisions of the food safety law; second, they are recorded in the Pharmacopoeia of traditional Chinese medicine; third, they have traditional eating habits; fourth, they are in line with the relevant laws and regulations on the protection of traditional Chinese medicine resources; fifth, they are listed in the national standards of traditional Chinese medicine Ye Zuguang (executive deputy director of National Engineering Research Center of traditional Chinese medicine compound new drugs) is well known that the R & D cycle of new drugs is long, it takes 15 years on average, and it generally takes more than 10 years in China to develop a new drug successfully New drug R & D investment is high In the United States, the average R & D investment for a new drug needs to exceed 1 billion US dollars The risk of new drugs is large, and the data statistics show that the success rate of new drug research and development in the United States is only one in ten thousand When we look at the allocation of R & D funds in the United States, we find that the new drug invention stage accounts for 82% of the R & D funds, and the product improvement stage accounts for 18% In our country